Learn why "Normal" Doesn't Always Equal Low Risk
Embedded Files
Now accepting new patients
-ABOUT THE FOUNDER
Dr. Rachna Relwani
Endocrinologist; Specialist in Early Cardiometabolic Risk
-----------------------------------------------------------------
"DesiDil exists so I can take care of patients the way I want my own family taken care of."
Seventeen-plus years of clinical practice. Board-certified in Endocrinology, Diabetes & Metabolism and in Internal Medicine. Recognized as one of Atlanta Magazine's Top Doctors and a Castle Connolly Top AAPI Doctor.
17+ years clinical practice 2 board certifications. Atlanta, GA
-THE MISSION
Clarity before disease
I focus on identifying cardiometabolic risk early—often years before it becomes visible on standard testing.
My work began with a focus on South Asians, a group known to develop heart disease earlier and more quietly. Over time, that lens expanded. I saw the same patterns in others whose risk is not fully captured—midlife patients, women undergoing metabolic shifts, Filipinos and other under-screened groups.
DesiDil was built to address this gap: precise answers, before disease develops.
-WHY THIS WORK IS PERSONAL
It started with my own family.
It started with my own family.
"My understanding of risk didn't come only from training. It came from experience."
My husband was a healthy, active 44-year-old: a father, an attorney, a tennis player. He had no chest pain — only nausea — before an unexpected cardiac event.
That experience changed how I understood risk. It made clear how often early warning signs are missed, especially in populations where disease presents differently.
As I looked deeper, a pattern emerged:
Risk was higher than expected.
Standard tests were reassuring — until they weren't.
There was no model designed to identify this early.
So I built what I could not find: a focused, prevention-first approach designed to identify risk while it is still preventable.
-THE APPROACH
Risk should be identified before it becomes obvious.
Risk should be identified before it becomes obvious.
We move beyond standard screenings using three lenses, integrated together.
01 Lipids
01 Lipids
Advanced Lipids
Particle patterns and markers like ApoB and Lp(a) — not just total cholesterol or LDL.
02 Metabolism
02 Metabolism
Metabolic Mapping
Early insulin resistance and visceral fat strain — often years before diabetes appears.
03 Context
03 Context
Clinical Context
Your specific genetics, family history, and trajectory — integrated into the read.
-CREDENTIALS
Board-Certified.
Faculty-Trained.
Published.
Over 17 years in practice.
A specialist in early cardiometabolic risk. My career has centered on identifying early metabolic dysfunction and its connection to long-term cardiovascular health.
BOARD CERTIFICATIONS
-Endocrinology, Diabetes and Metabolism
-Internal Medicine
EDUCATION & TRAINING
-Fellowship: Albert Einstein College of Medicine (Endocrinology)
-Residency: Yale Primary Care (Internal Medicine)
-Medical School: University of Alabama
ACADEMIC APPOINTMENTS
-Assistant Professor · New York University
-Guest lecturer · Morehouse School of Medicine
DISTINCTIONS
-Atlanta Magazine's Top Doctors, 2025
-Castle Connolly Top AAPI Doctor
-Castle Connolly Top Women in Medicine
-Multiple Top Doctor recognitions
IN THE MEDIA
-Featured in Khabar Magazine, NRI Pulse, and Healio
-National speaker on early cardiometabolic risk
-WHAT I BELIEVE
Four convictions that shape this practice
1 Prevention should begin before symptoms.
1 Prevention should begin before symptoms.
Once a symptom appears, prevention has already failed. The most valuable window is years earlier — quietly, before anything is obviously wrong.
----------------------------------------------------------------------------
3 Context matters as much as numbers.
3 Context matters as much as numbers.
A "normal" LDL means something different at 35 than at 55. With a family history of CAD it means something different again. Interpretation is the work.
2 Risk isn't always visible on standard testing.
2 Risk isn't always visible on standard testing.
For many groups, the markers that drive risk simply aren't in the routine panel. A "normal" result is not the same as a complete picture.
----------------------------------------------------------------------------
4 Clarity is more valuable than reassurance.
4 Clarity is more valuable than reassurance.
Reassurance feels good. Clarity changes outcomes. You leave with a precise read on where you stand — and what to do about it.
-READY WHEN YOU ARE
Want a Precise read on your risk?
If you're trying to understand your risk more precisely — before it becomes obvious — this work is designed for you.
Page updated
Report abuse